PMDA drug package insert
ピシリバクタ静注用0.75g
PMDA Prescription drug · 日医工株式会社 · package insert Apr 14, 2026
Key facts
| Brand names | ピシリバクタ静注用0.75g, ピシリバクタ静注用1.5g, ピシリバクタ静注用3g |
|---|---|
| Nonproprietary names | アンピシリンナトリウム・スルバクタムナトリウム |
| Companies | 製造販売元／日医工株式会社 |
| Product type | Prescription drug |
| Therapeutic category | β-ラクタマーゼ阻害剤配合抗生物質製剤 |
| Therapeutic category codes | 876139 |
| YJ codes | 6139504F1103, 6139504F2037, 6139504F3068 |
| Approval numbers | 22300AMX00923000, 21700AMZ00429000, 22700AMX00900000 |
| Package insert edition | 第3版 |
| Package insert date | Apr 14, 2026 |
| PMDA document key | 530169_6139504F1103_1 |
| PMDA company code | 530169 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: